AbbVie
This role involves conducting independent, publishable research in peptide synthesis process development within the Active Pharmaceutical Ingredient team. The successful candidate will apply advanced expertise in organic and peptide chemistry to support platform development for synthesizing and isolating peptide intermediates and drug substances. The position aims to generate new insights and methods that advance peptide process development while fostering the candidate's independence as a scientist.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
51% above the average for this role
Peptide Synthesis Specialist
Ellison Medical Institute of Los Angeles
Senior Principal Scientist, Peptide Chemistry / API Development
Neurocrine Biosciences
Post Doctoral Fellow
Saint Louis University
Senior Principal Scientist, Peptide Therapeutics
1000 Genentech, Inc.
Scientist I or II - Peptide Chemistry
City of Pierre, South Dakota
Scientist I or II - Peptide Chemistry
City of Winnipeg